Coagulo Medical Technologies, Inc.
Coagulo Medical Technologies is transforming medicine with the first portable and connected precision-medicine platform for smarter management of coagulation, enabling better healthcare outcomes for everyone. The company combines patent-pending coagulation assays, cutting-edge microfluidic technology, and proprietary data analytics to deliver accessible and personalized diagnosis and management of coagulation-related diseases.
Industries
N/A
Nr. of Employees
small (1-50)
Coagulo Medical Technologies, Inc.
2000 Commonwealth Ave, Suite 200, Auburndale, MA, 02466, United States
Products
Portable connected point-of-care coagulation testing platform (investigational)
A portable, automated point-of-care diagnostic platform that runs multiplex coagulation assays from drops of whole blood, provides results within ~10 minutes, identifies factor-specific abnormalities, quantifies anticoagulant effect, and offers digital connectivity for trend monitoring. Intended for investigational use and clinical research.
Portable connected point-of-care coagulation testing platform (investigational)
A portable, automated point-of-care diagnostic platform that runs multiplex coagulation assays from drops of whole blood, provides results within ~10 minutes, identifies factor-specific abnormalities, quantifies anticoagulant effect, and offers digital connectivity for trend monitoring. Intended for investigational use and clinical research.
Services
Partnerships with hospitals and academic centers to run clinical studies, generate clinical performance data, and co-develop diagnostic workflows for coagulation and anticoagulant management.
Development services to adapt point-of-care coagulation testing systems for rugged or field use under government or institutional contracts.
Partnerships with hospitals and academic centers to run clinical studies, generate clinical performance data, and co-develop diagnostic workflows for coagulation and anticoagulant management.
Development services to adapt point-of-care coagulation testing systems for rugged or field use under government or institutional contracts.
Expertise Areas
- Point-of-care diagnostics
- Coagulation diagnostics and anticoagulant monitoring
- Pediatric coagulation monitoring
- Clinical validation and hospital-based studies
Key Technologies
- Microfluidics
- Multiplex coagulation assays
- Low-volume whole-blood sampling
- Point-of-care automated readers
News & Updates
Coagulo to present data on the use of the POC Testing System for the detection of apixaban in patients with intracranial hemorrhage
Coagulo will present data at ISTH 2023.
Case report published with Mass General Brigham
The case report discusses the use of Coagulo’s POC testing to monitor argotraban treatment in a patient with antiphospholipid syndrome, HIT, and COVID-19 pneumonia.
Publication on Coagulo’s technology to detect anticoagulation resistance
The publication discusses prediction of thrombotic events in pediatric patients requiring ECMO treatment with Texas Children’s Hospital.
Coagulo awarded a multi-million dollar contract with the Department of Defense
The contract is for the development of a ruggedized coagulation testing system to be used in austere conditions.
Massachusetts General Hospital presents clinical data on Coagulo’s technology
The data presentation is for complex anticoagulant management at the 2022 Society of Critical Care Medicine Congress.
Finalist in the American College of Emergency Physicians Medical Device competition
Coagulo was recognized as a finalist in this prestigious competition.
Coagulo to present data on the use of the POC Testing System for the detection of apixaban in patients with intracranial hemorrhage
Coagulo will present data at ISTH 2023.
Case report published with Mass General Brigham
The case report discusses the use of Coagulo’s POC testing to monitor argotraban treatment in a patient with antiphospholipid syndrome, HIT, and COVID-19 pneumonia.
Publication on Coagulo’s technology to detect anticoagulation resistance
The publication discusses prediction of thrombotic events in pediatric patients requiring ECMO treatment with Texas Children’s Hospital.
Coagulo awarded a multi-million dollar contract with the Department of Defense
The contract is for the development of a ruggedized coagulation testing system to be used in austere conditions.
Massachusetts General Hospital presents clinical data on Coagulo’s technology
The data presentation is for complex anticoagulant management at the 2022 Society of Critical Care Medicine Congress.
Finalist in the American College of Emergency Physicians Medical Device competition
Coagulo was recognized as a finalist in this prestigious competition.